298 related articles for article (PubMed ID: 30062181)
1. Cardioprotective Effects of LCZ696 (Sacubitril/Valsartan) After Experimental Acute Myocardial Infarction.
Ishii M; Kaikita K; Sato K; Sueta D; Fujisue K; Arima Y; Oimatsu Y; Mitsuse T; Onoue Y; Araki S; Yamamuro M; Nakamura T; Izumiya Y; Yamamoto E; Kojima S; Kim-Mitsuyama S; Ogawa H; Tsujita K
JACC Basic Transl Sci; 2017 Dec; 2(6):655-668. PubMed ID: 30062181
[TBL] [Abstract][Full Text] [Related]
2. Pharmacodynamic and Pharmacokinetic Profiles of Sacubitril/Valsartan (LCZ696) in Patients with Heart Failure and Reduced Ejection Fraction.
Kobalava Z; Kotovskaya Y; Averkov O; Pavlikova E; Moiseev V; Albrecht D; Chandra P; Ayalasomayajula S; Prescott MF; Pal P; Langenickel TH; Jordaan P; Rajman I
Cardiovasc Ther; 2016 Aug; 34(4):191-8. PubMed ID: 26990595
[TBL] [Abstract][Full Text] [Related]
3. Sacubitril/valsartan (LCZ696) significantly reduces aldosterone and increases cGMP circulating levels in a canine model of RAAS activation.
Mochel JP; Teng CH; Peyrou M; Giraudel J; Danhof M; Rigel DF
Eur J Pharm Sci; 2019 Feb; 128():103-111. PubMed ID: 30508581
[TBL] [Abstract][Full Text] [Related]
4. Combination of LCZ696 and ACEI further improves heart failure and myocardial fibrosis after acute myocardial infarction in mice.
Liu Y; Fan Y; Li J; Chen M; Chen A; Yang D; Guan X; Cao Y
Biomed Pharmacother; 2021 Jan; 133():110824. PubMed ID: 33378988
[TBL] [Abstract][Full Text] [Related]
5. Sacubitril/valsartan: An important piece in the therapeutic puzzle of heart failure.
Marques da Silva P; Aguiar C
Rev Port Cardiol; 2017 Sep; 36(9):655-668. PubMed ID: 28844335
[TBL] [Abstract][Full Text] [Related]
6. Sacubitril/Valsartan (LCZ696) in Heart Failure.
Khder Y; Shi V; McMurray JJV; Lefkowitz MP
Handb Exp Pharmacol; 2017; 243():133-165. PubMed ID: 28004291
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin receptor neprilysin inhibitor LCZ696 attenuates cardiac remodeling and dysfunction after myocardial infarction by reducing cardiac fibrosis and hypertrophy.
von Lueder TG; Wang BH; Kompa AR; Huang L; Webb R; Jordaan P; Atar D; Krum H
Circ Heart Fail; 2015 Jan; 8(1):71-8. PubMed ID: 25362207
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin receptor neprilysin inhibition provides superior cardioprotection compared to angiotensin converting enzyme inhibition after experimental myocardial infarction.
Kompa AR; Lu J; Weller TJ; Kelly DJ; Krum H; von Lueder TG; Wang BH
Int J Cardiol; 2018 May; 258():192-198. PubMed ID: 29544929
[TBL] [Abstract][Full Text] [Related]
9. Focus on the Novel Cardiovascular Drug LZC696: from Evidence to Clinical Consideration.
Lin LM; Wu Y; Wu MF; Lin JX
Cardiovasc Drugs Ther; 2016 Dec; 30(6):623-633. PubMed ID: 27858191
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of sacubitril/valsartan (LCZ696) in Japanese patients with chronic heart failure and reduced ejection fraction: Rationale for and design of the randomized, double-blind PARALLEL-HF study.
Tsutsui H; Momomura S; Saito Y; Ito H; Yamamoto K; Ohishi T; Okino N; Guo W
J Cardiol; 2017 Sep; 70(3):225-231. PubMed ID: 28024961
[TBL] [Abstract][Full Text] [Related]
11. The Efficacy of Angiotensin Receptor-Neprilysin Inhibitor Versus Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Post Myocardial Infarction: A Meta-Analysis.
Kotak S; Hassan W; Mehmood M; Kumar U; Sagreeka F; Karishma F; Kumari P; Pirya F; Saquib J; Iqbal A; Khan AA; Varrassi G; Khatri M; Kumar S
Cureus; 2023 Oct; 15(10):e46547. PubMed ID: 37933369
[TBL] [Abstract][Full Text] [Related]
12. Dual Angiotensin Receptor and Neprilysin Inhibition with Sacubitril/Valsartan in Chronic Systolic Heart Failure: Understanding the New PARADIGM.
Lillyblad MP
Ann Pharmacother; 2015 Nov; 49(11):1237-51. PubMed ID: 26175499
[TBL] [Abstract][Full Text] [Related]
13. Neprilysin Inhibitors in Heart Failure: The Science, Mechanism of Action, Clinical Studies, and Unanswered Questions.
Bozkurt B; Nair AP; Misra A; Scott CZ; Mahar JH; Fedson S
JACC Basic Transl Sci; 2023 Jan; 8(1):88-105. PubMed ID: 36777165
[TBL] [Abstract][Full Text] [Related]
14. Prevention against renal damage in rats with subtotal nephrectomy by sacubitril/valsartan (LCZ696), a dual-acting angiotensin receptor-neprilysin inhibitor.
Ushijima K; Ando H; Arakawa Y; Aizawa K; Suzuki C; Shimada K; Tsuruoka SI; Fujimura A
Pharmacol Res Perspect; 2017 Aug; 5(4):. PubMed ID: 28805977
[TBL] [Abstract][Full Text] [Related]
15. Sacubitril Valsartan Enhances Cardiac Function and Alleviates Myocardial Infarction in Rats through a SUV39H1/SPP1 Axis.
Shen JF; Fan ZB; Wu CW; Qi GX; Cao QY; Xu F
Oxid Med Cell Longev; 2022; 2022():5009289. PubMed ID: 36193085
[TBL] [Abstract][Full Text] [Related]
16. NT-proBNP Response to Sacubitril/Valsartan in Hospitalized Heart Failure Patients With Reduced Ejection Fraction: TRANSITION Study.
Pascual-Figal D; Wachter R; Senni M; Bao W; Noè A; Schwende H; Butylin D; Prescott MF;
JACC Heart Fail; 2020 Oct; 8(10):822-833. PubMed ID: 32800508
[TBL] [Abstract][Full Text] [Related]
17. Sacubitril/valsartan (LCZ696) for the treatment of heart failure.
Gori M; Senni M
Expert Rev Cardiovasc Ther; 2016; 14(2):145-53. PubMed ID: 26642078
[TBL] [Abstract][Full Text] [Related]
18. The evolution of natriuretic peptide augmentation in management of heart failure and the role of sacubitril/valsartan.
Yandrapalli S; Aronow WS; Mondal P; Chabbott DR
Arch Med Sci; 2017 Aug; 13(5):1207-1216. PubMed ID: 28883863
[TBL] [Abstract][Full Text] [Related]
19. Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition.
Hubers SA; Brown NJ
Circulation; 2016 Mar; 133(11):1115-24. PubMed ID: 26976916
[TBL] [Abstract][Full Text] [Related]
20. Effects of Sacubitril/Valsartan on N-Terminal Pro-B-Type Natriuretic Peptide in Heart Failure With Preserved Ejection Fraction.
Cunningham JW; Vaduganathan M; Claggett BL; Zile MR; Anand IS; Packer M; Zannad F; Lam CSP; Janssens S; Jhund PS; Kober L; Rouleau J; Shah SJ; Chopra VK; Shi VC; Lefkowitz MP; Prescott MF; Pfeffer MA; McMurray JJV; Solomon SD
JACC Heart Fail; 2020 May; 8(5):372-381. PubMed ID: 32241619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
